573-31957-28240 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-03
Registered in v-safe
2021-01-03
Dose 1 — Pfizer-BioNTech
2021-01-03
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Muscle or body aches, Nausea

Adult check-in
2021-01-10
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-17
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-24
Dose 2 — Pfizer-BioNTech
2021-02-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-07
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-27
Survey response — 3 months, dose 2
MedDRA: Pre-existing disease, Respiratory tract congestion — Feeling: Fair

Free text: Congested, seasonal allergies

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-27
Survey response — 6 months, dose 2
MedDRA: Abortion spontaneous, Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pregnancy and miscarriage

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-27
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-02
Call 1 — Left Voicemail
2022-01-26
Survey response — 12 months, dose 2
MedDRA: Nasopharyngitis, Upper respiratory tract infection — Feeling: Good

Free text: URI cold symptoms

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-03	Pfizer-BioNTech
2	2021-01-24	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-07-27	Unsuccessful

Free text

Release 8 — 3 months, dose 2

2021-04-27

Symptoms: Congested, seasonal allergies

Release 9 — 6 months, dose 2

2021-07-27

Symptoms: Pregnancy and miscarriage

Release 11 — 12 months, dose 2

2022-01-26

Symptoms: URI cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	✓	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Pregnancy	✓	·	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Upper respiratory tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release